| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director
1 company
Harris Matthew Scott is a Chief Medical Officer at Altimmune, Inc.. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $43K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | ALT Altimmune, Inc. | Chief Medical Officer | Buy | 10,000 | $4.22 | $42,200.00 | +42.9% | 0.0% | +116.7% | |
| Feb 28, 2022 | ALT Altimmune, Inc. | Chief Medical Officer | Sale+OE | 30,000 | $7.52 | $225,600.00 | -72.2% | -31.7% | +69.9% | |
| Nov 12, 2020 | ALT Altimmune, Inc. | Director | Sell | 4,015 | $10.02 | $40,230.30 | -49.7% | - | - |